Employing the European Thyroid Imaging Reporting and Data System 2017 classification in a malignancy risk stratification system for thyroid nodules at Can Tho Oncology Hospital from 2021 to 2023

Vo Van Kha; Tran Thi Huong Ly; Pham Thi Thanh Hoa; Vo Huynh Nhu; Damas Hendriansyah; Nusratuddin Abdullah; Rudy B. Leonardy; Mardiah Tahir; Samrichard Rambulangi; Firdaus Hamid; Filomena Pietrantonio; Vera Kopsaj; Francesco Rosiello; Aurora Tomassoni; Luca Moriconi; Donatella Padua; Kiki Rizki Amelia; Efendi Lukas; Nurbani Bangsawan; Isharyah Sunarno; Retno Budiarti Farid; Sriwijaya Qadar; Rabab H. Elshaikh; Ashok Kumar Sah; Abdelrahman Mohamed Abukanna; Abdulrahman Algarni; Ammar Abdelmola; Hussam Ali Osman; Tagwa Yousif Elsayed Yousif; Elryah I. Ali; Hiba Ali; Ayman Hussein Alfeel; Thanh Long Nguyen; Victor Storm; Lam Toi Phung; Cong Thien Le; Thi Thu Ha Le; Thi Hoa Nguyen; Son Tung Vu; Thien Thang Tran; Minh Hanh Vu; Van Tuan Nguyen; Francesco Ventrella; Anna Belfiore; Antonio Greco; Franco Mastroianni; Salvatore Lenti; Domenico Ruggiero; Michele Cannone; Vincenzo Ostilio Palmieri; Massimo Errico; Giuseppe Mancia; Guido Grassi; Sverre E. Kjeldsen

doi:10.4081/itjm.2025.1852

Search

Search articles for

Advanced filters

Published AfterYearMonthDay

Published BeforeYearMonthDay

By Author

By Section

Search Results

##search.searchResults.foundPlural##

Old and new oral anticoagulants for secondary stroke prevention in atrial fibrillation

Tommaso Sacquegna, Anna Zaniboni, Andrea Rubboli, Gaetano Procaccianti, Michela Crisci, Fabiola Maioli, Giorgia Arnone, Giuseppe Di Pasquale

314-322

15-12-2015

https://doi.org/10.4081/itjm.2015.468

1954

PDF: 898

HTML: 1232
Stroke prevention in atrial fibrillation: findings from Tuscan FADOI Stroke Registry

Luca Masotti, Rinaldo Innocenti, Stefano Spolveri, Irene Chiti, Grazia Panigada, Cristiana Seravalle, Giancarlo Landini, Alberto Fortini, Rino Migliacci, Raffaele Laureano, for Tuscan FADOI Stroke Registry Investigators

134-140

12-06-2014

https://doi.org/10.4081/itjm.2014.450

1572

PDF: 1226

Appendix: 567

HTML: 622
Cryptogenic stroke

Michele Stornello, Roberto Cappellani, Giuseppe Micieli, Simona Sacco, Stefano Spolveri, Roberto Sterzi, Danilo Toni, Antonio Carolei

185-194

30-09-2016

https://doi.org/10.4081/itjm.2016.682

1894

PDF: 1096

HTML: 585
The incidence of bleeding in patients with nonvalvular atrial fibrillation using anticoagulants: a real-world report with the biggest Vietnamese data

Bui The Dung, Cao Ngoc Mai Han, Tran Hoa, Nguyen Thanh Hien

17-02-2025

https://doi.org/10.4081/itjm.2025.1807

1824

PDF: 266

HTML: 1
Cryptogenic strokes and embolic strokes of unknown source: lights and shadows of a new construct

Marco Masina

171-174

30-09-2016

https://doi.org/10.4081/itjm.2016.720

1407

PDF: 858

HTML: 635
Assessment and predictors of inappropriate dose of direct oral anticoagulants

Mosaad O. Almegren

09-01-2024

https://doi.org/10.4081/itjm.2024.1679

892

pdf: 419

HTML: 123
Young FADOI and gender medicine: sex gender differences in cardiovascular disease

Tiziana Ciarambino, Miriam Gino, Paola Gnerre, Elena Barbagelata, Nunzia Barone, Francesca Saladini, Federica Lorenzi, Marta Zanon, Maria Cristina Pasquini, Cecilia Politi

23-31

20-03-2018

https://doi.org/10.4081/itjm.2018.864

2633

PDF: 1117

HTML: 478
Direct oral anticoagulants for secondary prevention in patients with non-valvular atrial fibrillation

Luca Masotti, Mario Di Napoli, Walter Ageno, Davide Imberti, Cecilia Becattini, Maurizio Paciaroni, Daniel Augustin Godoy, Roberto Cappelli, Giancarlo Landini, Grazia Panigada, Ido Iori, Domenico Prisco, Giancarlo Agnelli

8-21

24-12-2013

https://doi.org/10.4081/itjm.2013.s8.8

1310

PDF: 855
A dangerous adverse event in the use of dabigatran

Manuel Monti, Giovanni Maria Vincentelli, Francesco Borgognoni, Giuseppe Murdolo, Feliciano Menghini

250-251

09-11-2015

https://doi.org/10.4081/itjm.2015.629

1594

PDF: 890

HTML: 254
Efficacy and safety of new oral anticoagulants compared with warfarin in cardioembolic prophylaxis of patients with non valvular atrial fibrillation. More lights than shadows

Luca Masotti, Mario Di Napoli, Walter Ageno, Davide Imberti, Daniel Godoy, Grazia Panigada, NiccolÃ² Napoli, Giancarlo Landini, Roberto Cappelli, Ido Iori, Domenico Prisco, Giancarlo Agnelli

153-169

23-10-2012

https://doi.org/10.4081/itjm.2012.153

1680

PDF: 1978
New anticoagulant drugs versus warfarin in atrial fibrillation: economic evaluation and cost-effectiveness analysis

Mauro Silingardi

65-70

24-12-2013

https://doi.org/10.4081/itjm.2013.s8.65

1339

PDF: 935

1 - 11 of 11 items

Search

Search Results

Old and new oral anticoagulants for secondary stroke prevention in atrial fibrillation

Stroke prevention in atrial fibrillation: findings from Tuscan FADOI Stroke Registry

Cryptogenic stroke

The incidence of bleeding in patients with nonvalvular atrial fibrillation using anticoagulants: a real-world report with the biggest Vietnamese data

Cryptogenic strokes and embolic strokes of unknown source: lights and shadows of a new construct

Assessment and predictors of inappropriate dose of direct oral anticoagulants

Young FADOI and gender medicine: sex gender differences in cardiovascular disease

Direct oral anticoagulants for secondary prevention in patients with non-valvular atrial fibrillation

A dangerous adverse event in the use of dabigatran

Efficacy and safety of new oral anticoagulants compared with warfarin in cardioembolic prophylaxis of patients with non valvular atrial fibrillation. More lights than shadows

New anticoagulant drugs versus warfarin in atrial fibrillation: economic evaluation and cost-effectiveness analysis

authors

reviewers

indexing

Categories

Keywords